Key Insights

Highlights

Success Rate

85% trial completion

Published Results

18 trials with published results (12%)

Research Maturity

67 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.9%

12 terminated out of 152 trials

Success Rate

84.8%

-1.7% vs benchmark

Late-Stage Pipeline

6%

9 trials in Phase 3/4

Results Transparency

27%

18 of 67 completed with results

Key Signals

18 with results85% success12 terminated

Data Visualizations

Phase Distribution

97Total
Not Applicable (38)
Early P 1 (5)
P 1 (17)
P 2 (28)
P 3 (7)
P 4 (2)

Trial Status

Completed67
Recruiting35
Unknown14
Active Not Recruiting12
Terminated12
Not Yet Recruiting6

Trial Success Rate

84.8%

Benchmark: 86.5%

Based on 67 completed trials

Clinical Trials (152)

Showing 20 of 20 trials
NCT07729852Phase 2Not Yet RecruitingPrimary

Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France

NCT03648905Completed

Clinical Laboratory Evaluation of Chronic Autonomic Failure

NCT05699460Completed

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

NCT07197866Phase 2RecruitingPrimary

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

NCT06568237Phase 2RecruitingPrimary

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

NCT06706622Phase 3Active Not RecruitingPrimary

A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

NCT07657520RecruitingPrimary

High-Altitude Neurodegeneration Cohort (HANC) Study

NCT02994719Active Not Recruiting

Gait Analysis in Neurological Disease

NCT04782830Not ApplicableRecruiting

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

NCT07570212Not ApplicableRecruiting

Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders

NCT03924414Phase 4Completed

Trial of Parkinson's And Zoledronic Acid

NCT05807373Not ApplicableCompleted

Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis - Part 2

NCT00465790Completed

Research of Biomarkers in Parkinson Disease

NCT06501469Active Not Recruiting

Biomarkers in Parkinsonian Syndromes

NCT07644013RecruitingPrimary

Prospective Multicenter Registry Study of Multiple System Atrophy in China

NCT05167721Phase 2Active Not RecruitingPrimary

Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy

NCT06868628Phase 2RecruitingPrimary

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

NCT01799915Recruiting

Natural History Study of Synucleinopathies

NCT01136213Not ApplicableCompletedPrimary

Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study

NCT05526391Phase 2CompletedPrimary

A Study of TAK-341 in Treatment of Multiple System Atrophy

Scroll to load more

Research Network

Activity Timeline